PL1713461T3 - Związki o działaniu przeciwnowotworowym - Google Patents

Związki o działaniu przeciwnowotworowym

Info

Publication number: PL1713461T3
Authority: PL; Poland
Prior art keywords: compounds; antitumor activity; antitumor; activity
Prior art date: 2004-02-12

Application number

PL05707260T

Other languages

English (en)

Inventor

Gianfranco Peluso

Menotti Calvani

Original Assignee

Defiante Farm S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-12

Filing date

2005-02-08

Publication date

2011-01-31

2005-02-08 Application filed by Defiante Farm S A filed Critical Defiante Farm S A

2011-01-31 Publication of PL1713461T3 publication Critical patent/PL1713461T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL05707260T 2004-02-12 2005-02-08 Związki o działaniu przeciwnowotworowym PL1713461T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IT000230A ITMI20040230A1 (it)	2004-02-12	2004-02-12	Composti ad attivita' antitumorale
EP05707260A EP1713461B1 (en)	2004-02-12	2005-02-08	Compounds having antitumor activity
PCT/EP2005/001257 WO2005077354A1 (en)	2004-02-12	2005-02-08	Compounds having antitumor activity

Publications (1)

Publication Number	Publication Date
PL1713461T3 true PL1713461T3 (pl)	2011-01-31

Family

ID=34856910

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05707260T PL1713461T3 (pl)	2004-02-12	2005-02-08	Związki o działaniu przeciwnowotworowym

Country Status (19)

Country	Link
US (1)	US7652066B2 (pl)
EP (1)	EP1713461B1 (pl)
JP (1)	JP2007522165A (pl)
KR (1)	KR101220331B1 (pl)
CN (1)	CN1917867B (pl)
AR (1)	AR047742A1 (pl)
AT (1)	ATE476973T1 (pl)
AU (1)	AU2005211906B2 (pl)
BR (1)	BRPI0507664A (pl)
CA (1)	CA2556069C (pl)
CY (1)	CY1111048T1 (pl)
DE (1)	DE602005022828D1 (pl)
DK (1)	DK1713461T3 (pl)
ES (1)	ES2350695T3 (pl)
IT (1)	ITMI20040230A1 (pl)
PL (1)	PL1713461T3 (pl)
SI (1)	SI1713461T1 (pl)
TW (1)	TWI361802B (pl)
WO (1)	WO2005077354A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8314144B2 (en) *	2004-02-12	2012-11-20	Defiante Farmaceutica, S.A.	Compounds having antitumor activity
US8410150B2 (en)	2007-03-09	2013-04-02	University Health Network	Inhibitors of carnitine palmitoyltransferase and treating cancer
US8680282B2 (en)	2007-08-01	2014-03-25	University Health Network	Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
MX2010008196A (es) *	2008-04-29	2010-08-11	Hoffmann La Roche	Derivados de acido 4-dimetilaminobutirico.
KR20110044209A (ko) *	2008-06-24	2011-04-28	다라 바이오싸이언시즈, 아이엔씨.	효소 억제제 및 그의 용도
JP5746988B2 (ja) *	2012-02-15	2015-07-08	ライオン株式会社	カプセル皮膜及びカプセル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1299266B1 (it) *	1998-05-15	2000-02-29	Sigma Tau Ind Farmaceuti	Inibitori reversibili della carnitina palmitoil trasferasi
DE60028996T2 (de) *	1999-11-12	2007-02-08	The Johns Hopkins University School Of Medicine	Behandlung von krebs durch erhöhung des malonyl-coa-spiegels

2004
- 2004-02-12 IT IT000230A patent/ITMI20040230A1/it unknown
2005
- 2005-02-05 TW TW094103976A patent/TWI361802B/zh not_active IP Right Cessation
- 2005-02-08 SI SI200531145T patent/SI1713461T1/sl unknown
- 2005-02-08 PL PL05707260T patent/PL1713461T3/pl unknown
- 2005-02-08 BR BRPI0507664-1A patent/BRPI0507664A/pt not_active IP Right Cessation
- 2005-02-08 ES ES05707260T patent/ES2350695T3/es not_active Expired - Lifetime
- 2005-02-08 EP EP05707260A patent/EP1713461B1/en not_active Expired - Lifetime
- 2005-02-08 WO PCT/EP2005/001257 patent/WO2005077354A1/en not_active Ceased
- 2005-02-08 KR KR1020067015984A patent/KR101220331B1/ko not_active Expired - Fee Related
- 2005-02-08 AU AU2005211906A patent/AU2005211906B2/en not_active Ceased
- 2005-02-08 JP JP2006552526A patent/JP2007522165A/ja not_active Ceased
- 2005-02-08 DK DK05707260.5T patent/DK1713461T3/da active
- 2005-02-08 AT AT05707260T patent/ATE476973T1/de active
- 2005-02-08 CN CN2005800046288A patent/CN1917867B/zh not_active Expired - Fee Related
- 2005-02-08 CA CA2556069A patent/CA2556069C/en not_active Expired - Fee Related
- 2005-02-08 DE DE602005022828T patent/DE602005022828D1/de not_active Expired - Lifetime
- 2005-02-08 US US10/585,972 patent/US7652066B2/en not_active Expired - Fee Related
- 2005-02-11 AR ARP050100510A patent/AR047742A1/es not_active Application Discontinuation
2010
- 2010-11-03 CY CY20101100990T patent/CY1111048T1/el unknown

Also Published As

Publication number	Publication date
AR047742A1 (es)	2006-02-15
ATE476973T1 (de)	2010-08-15
KR101220331B1 (ko)	2013-01-09
ES2350695T3 (es)	2011-01-26
EP1713461A1 (en)	2006-10-25
KR20060134059A (ko)	2006-12-27
WO2005077354A1 (en)	2005-08-25
CA2556069A1 (en)	2005-08-25
CN1917867A (zh)	2007-02-21
DE602005022828D1 (de)	2010-09-23
US7652066B2 (en)	2010-01-26
CN1917867B (zh)	2011-03-16
DK1713461T3 (da)	2010-11-22
TW200530154A (en)	2005-09-16
EP1713461B1 (en)	2010-08-11
CY1111048T1 (el)	2015-06-11
BRPI0507664A (pt)	2007-07-17
US20080227683A1 (en)	2008-09-18
CA2556069C (en)	2013-04-23
TWI361802B (en)	2012-04-11
AU2005211906B2 (en)	2009-07-30
SI1713461T1 (sl)	2010-12-31
HK1099687A1 (en)	2007-08-24
AU2005211906A1 (en)	2005-08-25
JP2007522165A (ja)	2007-08-09
ITMI20040230A1 (it)	2004-05-12

Publication	Publication Date	Title
GB0420156D0 (en)	2004-10-13	Catalysis
GB0412914D0 (en)	2004-07-14	Compounds
GB0405193D0 (en)	2004-04-21	Compounds
EP1719527A4 (en)	2012-08-29	ANTITUMORAL MEDIUM
GB0401269D0 (en)	2004-02-25	Compounds
TWI372048B (en)	2012-09-11	Anti-coronavirus compounds
SI1713461T1 (sl)	2010-12-31	Spojine s protitumorsko aktivnostjo
GB0405101D0 (en)	2004-04-07	Compounds
GB0424565D0 (en)	2004-12-08	Activity aid
GB0405280D0 (en)	2004-04-21	Compounds
GB0403593D0 (en)	2004-03-24	Compounds
ZA200606475B (en)	2008-11-26	Compounds
GB0405970D0 (en)	2004-04-21	Concept seven
GB0521886D0 (en)	2005-12-07	Glycosyltrasferase activity
GB0405248D0 (en)	2004-04-21	Compounds
GB0400697D0 (en)	2004-02-18	Compounds
GB0405099D0 (en)	2004-04-07	Compounds
GB0404104D0 (en)	2004-03-31	Compounds
GB0404084D0 (en)	2004-03-31	Compounds
GB0404083D0 (en)	2004-03-31	Compounds
GB0404081D0 (en)	2004-03-31	Compounds
GB0403998D0 (en)	2004-03-31	Compounds
GB0403993D0 (en)	2004-03-31	Compounds
GB0405198D0 (en)	2004-04-21	Compounds
GB0403594D0 (en)	2004-03-24	Compounds